Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis
- Rodrigues, G.
- Oberije, C.
- Senan, S.
- Tsujino, K.
- Wiersma, T.
- Moreno-Jimenez, M.
- Kim, T.H.
- Marks, L.B.
- Rengan, R.
- De Petris, L.
- Ramella, S.
- DeRuyck, K.
- Rodriguez De Dios, N.
- Warner, A.
- Bradley, J.D.
- Palma, D.A.
ISSN: 1879-355X, 0360-3016
Year of publication: 2015
Volume: 91
Issue: 1
Pages: 133-139
Type: Article